IV TRC105: Phase IIa started

Tracon began the open-label Phase IIa portion of the U.S. Phase Ib/IIa trial of weekly IV TRC105 in combination with Votrient pazopanib in about 81 patients. The Phase IIa portion will evaluate the recommended combination identified in the dose-escalation Phase Ib portion in about 60 STS patients. ...